Using activation status of signaling pathways as mechanism-based biomarkers to predict drug sensitivity
Published 2015 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Using activation status of signaling pathways as mechanism-based biomarkers to predict drug sensitivity
Authors
Keywords
-
Journal
Scientific Reports
Volume 5, Issue 1, Pages -
Publisher
Springer Nature
Online
2015-12-18
DOI
10.1038/srep18494
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Identification of drug-specific pathways based on gene expression data: application to drug induced lung injury
- (2015) Ioannis N. Melas et al. Integrative Biology
- Prediction of human population responses to toxic compounds by a collaborative competition
- (2015) Federica Eduati et al. NATURE BIOTECHNOLOGY
- Babelomics 5.0: functional interpretation for new generations of genomic data
- (2015) Roberto Alonso et al. NUCLEIC ACIDS RESEARCH
- A Network Flow-Based Method to Predict Anticancer Drug Sensitivity
- (2015) Yufang Qin et al. PLoS One
- Identifying novel targets of oncogenic EGF receptor signaling in lung cancer through global phosphoproteomics
- (2015) Xu Zhang et al. PROTEOMICS
- Signaling pathways activation profiles make better markers of cancer than expression of individual genes
- (2015) Nikolay M. Borisov et al. Oncotarget
- Understanding disease mechanisms with models of signaling pathway activities
- (2014) Patricia Sebastian-Leon et al. BMC Systems Biology
- An argument for mechanism-based statistical inference in cancer
- (2014) Donald Geman et al. HUMAN GENETICS
- Tumor suppressor BLU promotes paclitaxel antitumor activity by inducing apoptosis through the down-regulation of Bcl-2 expression in tumorigenesis
- (2013) Sung Taek Park et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- Nilotinib induces apoptosis and autophagic cell death of activated hepatic stellate cells via inhibition of histone deacetylases
- (2013) Mohamed E. Shaker et al. BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR CELL RESEARCH
- Systems diagnostics: anticipating the next generation of diagnostic tests based on mechanistic insight into disease
- (2013) David A. Fryburg et al. DRUG DISCOVERY TODAY
- Genomics and transcriptomics in drug discovery
- (2013) Joaquin Dopazo DRUG DISCOVERY TODAY
- Autophagy stimulates apoptosis in HER2-overexpressing breast cancers treated by lapatinib
- (2013) Xingmei Zhu et al. JOURNAL OF CELLULAR BIOCHEMISTRY
- Sorafenib induces endometrial carcinoma apoptosis by inhibiting Elk-1-dependent Mcl-1 transcription and inducing Akt/GSK3β-dependent protein degradation
- (2013) Nian-Kang Sun et al. JOURNAL OF CELLULAR BIOCHEMISTRY
- Inhibition of Hedgehog signaling sensitizes NSCLC cells to standard therapies through modulation of EMT-regulating miRNAs
- (2013) Aamir Ahmad et al. Journal of Hematology & Oncology
- Comparison and validation of genomic predictors for anticancer drug sensitivity
- (2013) Simon Papillon-Cavanagh et al. JOURNAL OF THE AMERICAN MEDICAL INFORMATICS ASSOCIATION
- Inferring the functional effect of gene expression changes in signaling pathways
- (2013) Patricia Sebastián-León et al. NUCLEIC ACIDS RESEARCH
- The Reactome pathway knowledgebase
- (2013) David Croft et al. NUCLEIC ACIDS RESEARCH
- Data, information, knowledge and principle: back to metabolism in KEGG
- (2013) Minoru Kanehisa et al. NUCLEIC ACIDS RESEARCH
- Lapatinib alters the malignant phenotype of osteosarcoma cells via downregulation of the activity of the HER2-PI3K/AKT-FASN axis in vitro
- (2013) XIN-HUA LONG et al. ONCOLOGY REPORTS
- The ErbB/HER family of protein-tyrosine kinases and cancer
- (2013) Robert Roskoski PHARMACOLOGICAL RESEARCH
- Potentiating the Efficacy of Molecular Targeted Therapy for Hepatocellular Carcinoma by Inhibiting the Insulin-Like Growth Factor Pathway
- (2013) Da-Liang Ou et al. PLoS One
- CXC Chemokine Receptor 4 is Essential for Maintenance of Renal cell Carcinoma-Initiating Cells and Predicts Metastasis
- (2013) Maximilian Gassenmaier et al. STEM CELLS
- Treatment With Anticancer Agents Induces Dysregulation of Specific Wnt Signaling Pathways in Human Ovarian Luteinized Granulosa Cells In Vitro
- (2013) Ana Maria Sanchez et al. TOXICOLOGICAL SCIENCES
- Understanding cellular function and disease with comparative pathway analysis
- (2013) Melissa J Davis et al. Genome Medicine
- More power via graph-structured tests for differential expression of gene networks
- (2012) Laurent Jacob et al. Annals of Applied Statistics
- Identification of aberrant pathways and network activities from high-throughput data
- (2012) J. Wang et al. BRIEFINGS IN BIOINFORMATICS
- PPAR signaling pathway may be an important predictor of breast cancer response to neoadjuvant chemotherapy
- (2012) Y. Z. Chen et al. CANCER CHEMOTHERAPY AND PHARMACOLOGY
- Combined inhibition of EGFR and CK2 augments the attenuation of PI3K-Akt-mTOR signaling and the killing of cancer cells
- (2012) Joshua Bliesath et al. CANCER LETTERS
- Enhanced Apoptosis and Tumor Growth Suppression Elicited by Combination of MEK (Selumetinib) and mTOR Kinase Inhibitors (AZD8055)
- (2012) S. V. Holt et al. CANCER RESEARCH
- Tankyrase and the Canonical Wnt Pathway Protect Lung Cancer Cells from EGFR Inhibition
- (2012) Matias Casás-Selves et al. CANCER RESEARCH
- Wnt-Pathway Activation in Two Molecular Classes of Hepatocellular Carcinoma and Experimental Modulation by Sorafenib
- (2012) A. Lachenmayer et al. CLINICAL CANCER RESEARCH
- A Targeted Therapy for Protein and Lipid Kinases in Chronic Lymphocytic Leukemia
- (2012) P. Robak et al. CURRENT MEDICINAL CHEMISTRY
- Tracking molecular relapse of chronic myeloid leukemia by measuring Hedgehog signaling status
- (2012) Michele Cea et al. LEUKEMIA & LYMPHOMA
- Systematic identification of genomic markers of drug sensitivity in cancer cells
- (2012) Mathew J. Garnett et al. NATURE
- The Cancer Cell Line Encyclopedia enables predictive modelling of anticancer drug sensitivity
- (2012) Jordi Barretina et al. NATURE
- Along signal paths: an empirical gene set approach exploiting pathway topology
- (2012) Paolo Martini et al. NUCLEIC ACIDS RESEARCH
- Inhibiting oncogenic signaling by sorafenib activates PUMA via GSK3β and NF-κB to suppress tumor cell growth
- (2012) C Dudgeon et al. ONCOGENE
- Pathway-Based Evaluation in Early Onset Colorectal Cancer Suggests Focal Adhesion and Immunosuppression along with Epithelial-Mesenchymal Transition
- (2012) Seungyoon Nam et al. PLoS One
- Wnt/ -Catenin Signaling and AXIN1 Regulate Apoptosis Triggered by Inhibition of the Mutant Kinase BRAFV600E in Human Melanoma
- (2012) T. L. Biechele et al. Science Signaling
- Ten Years of Pathway Analysis: Current Approaches and Outstanding Challenges
- (2012) Purvesh Khatri et al. PLoS Computational Biology
- Emerging Signaling Pathways in Hepatocellular Carcinoma
- (2012) Agrin Moeini et al. Liver Cancer
- Systems Pharmacology: Network Analysis to Identify Multiscale Mechanisms of Drug Action
- (2011) Shan Zhao et al. Annual Review of Pharmacology and Toxicology
- Interactome Networks and Human Disease
- (2011) Marc Vidal et al. CELL
- Inhibition of autophagy potentiates the antitumor effect of the multikinase inhibitor sorafenib in hepatocellular carcinoma
- (2011) Satoshi Shimizu et al. INTERNATIONAL JOURNAL OF CANCER
- Epidermal growth factor receptor (EGFR) and squamous cell carcinoma of the skin: Molecular bases for EGFR-targeted therapy
- (2011) Pablo Uribe et al. PATHOLOGY RESEARCH AND PRACTICE
- Pharmacogenetics, Pharmacogenomics, and Individualized Medicine
- (2011) Q. Ma et al. PHARMACOLOGICAL REVIEWS
- Prediction model of potential hepatocarcinogenicity of rat hepatocarcinogens using a large-scale toxicogenomics database
- (2011) Takeki Uehara et al. TOXICOLOGY AND APPLIED PHARMACOLOGY
- Systems biology and the future of medicine
- (2011) Joseph Loscalzo et al. Wiley Interdisciplinary Reviews-Systems Biology and Medicine
- A sub-pathway-based approach for identifying drug response principal network
- (2010) Xiujie Chen et al. BIOINFORMATICS
- Predicting in vitro drug sensitivity using Random Forests
- (2010) Gregory Riddick et al. BIOINFORMATICS
- AZD6244 (ARRY-142886) enhances the antitumor activity of rapamycin in mouse models of human hepatocellular carcinoma
- (2010) Hung Huynh CANCER
- In vitro sequence-dependent synergism between paclitaxel and gefitinib in human lung cancer cell lines
- (2010) Hua Cheng et al. CANCER CHEMOTHERAPY AND PHARMACOLOGY
- Basal and Treatment-Induced Activation of AKT Mediates Resistance to Cell Death by AZD6244 (ARRY-142886) in Braf-Mutant Human Cutaneous Melanoma Cells
- (2010) Y. N. V. Gopal et al. CANCER RESEARCH
- The Insulin-Like Growth Factor Pathway in Lung Cancer
- (2010) Rafal Dziadziuszko et al. Journal of Thoracic Oncology
- Identification of Predictive Markers of Response to the MEK1/2 Inhibitor Selumetinib (AZD6244) in K-ras-Mutated Colorectal Cancer
- (2010) J. J. Tentler et al. MOLECULAR CANCER THERAPEUTICS
- Activated Phosphoinositide 3-Kinase/AKT Signaling Confers Resistance to Trastuzumab but not Lapatinib
- (2010) N. A. O'Brien et al. MOLECULAR CANCER THERAPEUTICS
- The MicroArray Quality Control (MAQC)-II study of common practices for the development and validation of microarray-based predictive models
- (2010) NATURE BIOTECHNOLOGY
- A chemical and phosphoproteomic characterization of dasatinib action in lung cancer
- (2010) Jiannong Li et al. Nature Chemical Biology
- Network medicine: a network-based approach to human disease
- (2010) Albert-László Barabási et al. NATURE REVIEWS GENETICS
- Hyperactivation of MEK–ERK1/2 signaling and resistance to apoptosis induced by the oncogenic B-RAF inhibitor, PLX4720, in mutant N-RAS melanoma cells
- (2010) F M Kaplan et al. ONCOGENE
- Synergistic Growth Inhibition of Squamous Cell Carcinoma of the Head and Neck by Erlotinib and Epigallocatechin-3-Gallate: The Role of p53-Dependent Inhibition of Nuclear Factor- B
- (2009) A. R. M. R. Amin et al. Cancer Prevention Research
- Microtubule-mediated NF-κB activation in the TNF-α signaling pathway
- (2009) Robert W. Jackman et al. EXPERIMENTAL CELL RESEARCH
- Analysis of Gene Sets Based on the Underlying Regulatory Network
- (2009) Ali Shojaie et al. JOURNAL OF COMPUTATIONAL BIOLOGY
- Molecular networks as sensors and drivers of common human diseases
- (2009) Eric E. Schadt NATURE
- Repeatability of published microarray gene expression analyses
- (2009) John P A Ioannidis et al. NATURE GENETICS
- Utilization of Genomic Signatures to Identify Phenotype-Specific Drugs
- (2009) Seiichi Mori et al. PLoS One
- A novel signaling pathway impact analysis
- (2008) Adi Laurentiu Tarca et al. BIOINFORMATICS
- Bidirectional Crosstalk between Leptin and Insulin-like Growth Factor-I Signaling Promotes Invasion and Migration of Breast Cancer Cells via Transactivation of Epidermal Growth Factor Receptor
- (2008) N. K. Saxena et al. CANCER RESEARCH
- RNA-Seq: a revolutionary tool for transcriptomics
- (2008) Zhong Wang et al. NATURE REVIEWS GENETICS
Create your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create NowAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started